The quarterly EBITDA of the company has reached ₹1,791 crore, with a 12.5% year-on-year growth due to stable operating activities and maintained cost efficiency.
Gland Pharma also established that its version is bioequivalent and therapeutically equivalent to the reference listed drug.
The Day-Ahead Contingency and Term-Ahead Market (TAM), posted a volume of 1,684 MU, higher by 38% against 1,221 MU in May 2024.
Top gainers in the Indian Benchmark Index Sensex include Eternal, Bharti Airtel, Tech Mahindra, IndusInd Bank
The NFO is available for subscription from June 02 to June 16, 2025.
Markets are treating 25 bps rate cut as fait accompli; but the question is whether RBI will go to 50 bps?
In May 2025, mid-caps bounced; but old favourites like defence, railways, and capital markets were back
Indian benchmark indices ended lower on third consecutive session on June 3.
Here are some of the stocks that may see significant price movement today: Wipro, Texmaco, Tata Technologies, etc.
The sharp increase in the recent order pipeline was driven by various project wins, such as a 1 GWh BESS for state-owned SJVN Ltd., as well as customers orders.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
